0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Staphylococcus Aureus and Toxic Shock Syndrome |

Staphylococcus aureus Associated with Toxic Shock Syndrome: Phage Typing and Toxin Capability Testing

W. A. ALTEMEIER, M.D.; S. A. LEWIS, B.S.; P. M. SCHLIEVERT, Ph.D.; M. S. BERGDOLL, Ph.D.; H. S. BJORNSON, M.D., Ph.D.; J. L. STANECK, Ph.D.; and B. A. CRASS, B.S.
[+] Article and Author Information

▸Requests for reprints should be addressed to W.A. Altemeier, M.D.; Department of Surgery, University of Cincinnati Medical Center, 231 Bethesda Avenue; Cincinnati, OH 45229.


Cincinnati, Ohio; Minneapolis, Minnesota; and Madison, Wisconsin


© 1982 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1982;96(6_Part_2):978-982. doi:10.7326/0003-4819-96-6-978
Text Size: A A A

Phage type 29 Staphylococcus aureus was identified singly or with type 52 in 64.1% of 248 coded isolates from patients with toxic shock syndrome. These phage types also have a high capability of producing pyrogenic exotoxin C and enterotoxin F. The origin and development of these toxigenic strains were explored by studying 25 220 isolates of S. aureus stored in a staphylococcal bank between 1960 and 1979. A small percentage of phage types 29, 52 were found in I960, but their prevalence increased between 1961 and 1970, and continued at elevated levels through 1979. The toxigenic capabilities of these phage types were apparently acquired about 1971 and increased up to 1975. High levels of prevalence persisted during the following 4 years, and receded in 1980 and 1981. Other evidence during 1980 and 1981 indicates that these strains of S. aureus have become an important pathogen in surgical wounds, burns, and other infections.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)